Anyone who's been paying attention to the FDA's evolving thinking on cannabidiol (a derivative of cannabis also known as CBD) shouldn't have been at all surprised at the agency's January 26, 2023 announcement that there are too many unknowns about CBD products to regulate them as foods or supplements under the agency's current structure and called on Congress to create new rules for the massive and growing market. And, specifically, per FDA Deputy Commissioner (and Chair of the agency's CBD working group) Dr. Janet Woodcock, “We have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm.”
Read Full Article »
